Treatment with anticancer drugs for advanced pancreatic cancer: a systematic review

[1] Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries CA Cancer J Clin 71 209-249

[2] Ferlay J(2021)Pancreatic cancer: a review JAMA 326 851-862

[3] Siegel RL(2021)Symptom burden of patients with Advanced Pancreas Cancer (APC): a provincial cancer institute observational study Curr Oncol 28 2789-2800

[4] Laversanne M(2018)The symptom experience of patients with advanced pancreatic cancer: an integrative review Cancer Nurs 41 33-44

[5] Soerjomataram I(2014)Concepts and definitions for "actively dying," "end of life," "terminally ill," "terminal care," and "transition of care": a systematic review J Pain Symptom Manage 47 77-89

[6] Jemal A(2017)Locally advanced unresectable pancreatic cancer: American society of clinical oncology clinical practice guideline summary J Oncol Pract 13 265-269

[7] Park W(2020)Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma Mol Cancer 19 32-118

[8] Chawla A(2019)Pancreatic cancer: an emphasis on current perspectives in immunotherapy Crit Rev Oncog 24 105-91

[9] O'Reilly EM(2021)Efficacy of systemic oncological treatments in patients with advanced pancreatic cancer at high risk of dying in the short or medium-term: overview of systematic reviews Eur J Cancer 154 82-7392

[10] Lelond S(2023)Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map Support Care Cancer 31 100-e105

[1] Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries CA Cancer J Clin 71 209-249

[2] Ferlay J(2021)Pancreatic cancer: a review JAMA 326 851-862

[3] Siegel RL(2021)Symptom burden of patients with Advanced Pancreas Cancer (APC): a provincial cancer institute observational study Curr Oncol 28 2789-2800

[4] Laversanne M(2018)The symptom experience of patients with advanced pancreatic cancer: an integrative review Cancer Nurs 41 33-44

[5] Soerjomataram I(2014)Concepts and definitions for "actively dying," "end of life," "terminally ill," "terminal care," and "transition of care": a systematic review J Pain Symptom Manage 47 77-89

[6] Jemal A(2017)Locally advanced unresectable pancreatic cancer: American society of clinical oncology clinical practice guideline summary J Oncol Pract 13 265-269

[7] Park W(2020)Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma Mol Cancer 19 32-118

[8] Chawla A(2019)Pancreatic cancer: an emphasis on current perspectives in immunotherapy Crit Rev Oncog 24 105-91

[9] O'Reilly EM(2021)Efficacy of systemic oncological treatments in patients with advanced pancreatic cancer at high risk of dying in the short or medium-term: overview of systematic reviews Eur J Cancer 154 82-7392

[10] Lelond S(2023)Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map Support Care Cancer 31 100-e105